Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
HealthPartners Institute
With
Amylin Pharmaceuticals, LLC.
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
participant in Amylin Protocol 2993LAR-105
at least 16 years of age
type 2 diabetes being treated with stable regiment of metformin, SU, TZD, combination of metformin/SU, combination metformin/TZD, combination SU/TZD
A1c 7.1 - 11
fasting glucose less than 280 at screening
BMI 25 - 45
stable body weight 6 months prior to screening
not pregnant and willing to practice birth control
physical exam \& ECG not clinically significant
lab values judged not to be clinically significant
able to understand \& sign consent form
You may not be if
clinically significant medical condition as judged by investigator
drug or alcohol abuse
previous use of exenatide or any GLP-1 analog
has used any investigational drug in the past 30 days prior to screening
is currently using: alpha-glucosidase inhibitor, insulin, drugs that affect GI motility, use of systemic corticosteroids, use of medications with addictive potential, prescription or OTC weight-loss medications
has donated blood within 60 days of screening, or is planning to donate during the study
has had major surgery or blood transfusion within 2 months of screening
has had a surgical procedure that may impact gastric emptying
has any allergies or hypersensitivity to any component of study treatment
is an immediate family member of personnel affiliated with the study at the investigative site